Evidence map›Paper›PMID 34362310›Full record

ArticleBMC infectious diseases2021

Community-based model for the delivery of antiretroviral therapy in Cambodia: a quasi-experimental study protocol.

Sovannary Tuot, Alvin Kuo Jing Teo, Kiesha Prem, Pheak Chhoun, Chamroen Pall, Mengieng Ung, Penh Sun Ly, Masamine Jimba, Siyan Yi

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04766710 (Implementation and Evaluation of a Community-Based Model for Delivery of Antiretroviral Therapy in Cambodia), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04766710 naunknown statusnot on this map

Implementation and Evaluation of a Community-Based Model for Delivery of Antiretroviral Therapy in Cambodia: A Quasi-Experimental Study

TypeinterventionalSponsorNational University of SingaporeRan2021 to 2024Enrolled4,102ConditionsHIV Infections, AIDSArmsCommunity-based ART delivery (CAD), ART multi-month dispensing (MMD)
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 5 countries.

Sovannary Tuot *KHANA Center for Population Health Research, Phnom Penh, Cambodia.
Alvin Kuo Jing Teo *Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 12 Science Drive 2, #10-01, Singapore, 117549, Singapore.
Kiesha Prem *Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 12 Science Drive 2, #10-01, Singapore, 117549, Singapore.
Pheak ChhounKHANA Center for Population Health Research, Phnom Penh, Cambodia.
Chamroen PallKHANA Center for Population Health Research, Phnom Penh, Cambodia.
Mengieng UngKHANA Center for Population Health Research, Phnom Penh, Cambodia.
Penh Sun LyNational Center for HIV/AIDS, Dermatology and STD, Phnom Penh, Cambodia.
Masamine JimbaDepartment of Community and Global Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Siyan Yi *KHANA Center for Population Health Research, Phnom Penh, Cambodia. siyan@doctor.com.ORCID http://orcid.org/0000-0002-3045-5386
National University of Singapore · SGThe University of Tokyo · JPNational Center for HIV/AIDS, Dermatology and STD · KHSingapore University of Technology and Design · SG

Funding

Initiative % 19-SB0765
6 · The paper itself

Abstract

backgroundMulti-month dispensing (MMD) is the mainstay mechanism for clinically stable people living with HIV in Cambodia to refill antiretroviral therapy (ART) every 3-6 months. However, less frequent ART dispensing through the community-based ART delivery (CAD) model could further reduce the clients' and health facilities' burden. While community-based services have been recognized as an integral component of HIV response in Cambodia, their role and effectiveness in ART delivery have yet to be systematically assessed. This study aims to evaluate the CAD model's effectiveness on the continuum of care and treatment outcomes for stable people living with HIV in Cambodia.

methodsWe will conduct this quasi-experimental study in 20 ART clinics across the capital city and nine provinces between May 2021 and April 2023. Study sites were purposively selected based on the availability of implementing partners, the number of people living with HIV each clinic serves, and the accessibility of the clinics. In the intervention arm, approximately 2000 stable people living with HIV will receive ART and services from the CAD model. Another 2000 stable people living with HIV in the control arm will receive MMD-a standard care model for stable people living with HIV. The primary outcomes will be retention in care, viral load suppression, and adherence to ART. The secondary endpoints will include health providers' work burden, the model's cost-effectiveness, quality of life, mental health, social support, stigma, and discrimination. We will compare the outcome indicators within each arm at baseline, midline, and endline using descriptive and inferential statistics. We will evaluate the differences between the intervention and control arms using the difference-in-differences method. We will perform economic evaluations to determine if the intervention is cost-effective. DISCUSSION: This study will build the evidence base for future implementation and scale-up of CAD model in Cambodia and other similar settings. Furthermore, it will strengthen engagements with community stakeholders and further improve community mobilization, a vital pillar of the Cambodian HIV response.

trial registrationClinicalTrials.gov, NCT04766710 . Registered 23 February 2021, Version 1.

Indexed as

Anti-HIV AgentsHIV InfectionsCambodiaHumansQuality of LifeTime FactorsAnti-HIV AgentsAntiretroviral therapyCambodiaCommunityHIVImplementation scienceService delivery

Identifiers

PMID34362310
PMCPMC8344198
OpenAlexW3163488741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.